SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company Oct 25, 2021 07:39AM
SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company Oct 25, 2021 07:39AM
SAB Biotherapeutics to List on Nasdaq through Merger with Big Cypress Acquisition (BCYP) Jun 22, 2021 06:23AM
SAB Biotherapeutics to List on Nasdaq through Merger with Big Cypress Acquisition Corp., Advancing Unique Human Antibody Platform with Demonstrated Utility in Immunotherapy and Rapid Response to Emerg Jun 22, 2021 06:00AM